Transcriptome and Regulatory Network Analyses of CD19-CAR-T Immunotherapy for B-ALL

Chimeric antigen receptor (CAR) T cell therapy has exhibited dramatic anti-tumor efficacy in clinical trials. In this study, we reported the transcriptome profiles of bone marrow cells in four B cell acute lymphoblastic leukemia (B-ALL) patients before and after CD19-specific CAR-T therapy. CD19-CAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiong, Hu, Hui, Chen, Si-Yi, Liu, Chun-Jie, Hu, Fei-Fei, Yu, Jianming, Wu, Yaohui, Guo, An-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620363/
https://www.ncbi.nlm.nih.gov/pubmed/31201998
http://dx.doi.org/10.1016/j.gpb.2018.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620363/
https://www.ncbi.nlm.nih.gov/pubmed/31201998
http://dx.doi.org/10.1016/j.gpb.2018.12.008

Ejemplares similares